Long-term Follow-up of Subfoveal Neovascular AMD

Medical University of Vienna

Status: Unknown

Conditions: Exudative Age-related Macular Degeneration

Study type: Observational

Funder types: Other

Identifiers

NCT01608113

EK 802/2011

Details and patient eligibility

About

Treatment naive patients with subfoveal nAMD initially treated monthly with intravitreal anti-VEGF and subsequently PRN, will be included in this study. Patients will be investigated for the first 2 years monthly and subsequently according to disease activity but at least every two months. Patients will be examined with 4m BCVA ETDRS distance visual acuity, reading acuity measured by Radner-Reading-Charts, contrast sensitivity by Pelli-Robson score, microperimetry and HD-OCT.

Enrollment: 70 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• treatment naive subfoveal AMD, written informed consent, able to read

Exclusion criteria

• choroidal neovascularisation due to other ocular diseases, mature cataract